Methods and compositions for modulation of stem cell aging

Details for Australian Patent Application No. 2006311637 (hide)

Owner The General Hospital Corporation University of North Carolina at Chapel Hill

Inventors Sharpless, Norman E.; Janzen, Viktor; Forkert, Randolf; Scadden, David T.

Agent David Adamthwaite

Pub. Number AU-A-2006311637

PCT Pub. Number WO2007/056423

Priority 60/734,336 07.11.05 US

Filing date 7 November 2006

Wipo publication date 18 May 2007

International Classifications

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

29 May 2008 PCT application entered the National Phase

  PCT publication WO2007/056423 Priority application(s): WO2007/056423

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006311642-Systems and methods for a financial services reward program

2006311636-Modulation of IL-2 production by T-bet